About Us

For the past seven years, Paul Stinson has been intimately involved in Canada’s biotechnology and proteomics sectors. During four years as Executive Director of BC Biotech, he was a member of Canada’s Biotech Accord and attracted BioPartnering North America to Vancouver. In January 2005, he became the first Director General of HUPO, the Human Proteome Organisation, based in Montreal. He has now returned to Vancouver, where he has resurrected CAPRA International, his consulting firm which he “parked” between January 2001 and December 2005.

After seven years in the government sector, working in Ottawa and Singapore, Paul completed MBA studies at IMD in Lausanne, Switzerland in December 1985. He spent the next seven years at Ciba-Geigy, in Switzerland, Canada, and Zimbabwe. In 1993, he moved to India, where he was Managing Director of Boehringer Mannheim India, an operation with 1,200 employees and $25 million USD in sales, until September 1996.

CAPRA allows Paul to build upon the skills and contacts which he acquired over twenty years in the biopharmaceutical and medical devices sectors.

Paul established CAPRA in January 1997 and participated in the 1997 Team Canada trade mission to Thailand. Thereafter, he undertook a one-year consulting assignment with Innovara, a boutique consulting firm to the pharmaceutical industry, based in Massachusetts. On his return to Vancouver, he was Managing Director of UBC’s Centre for Molecular Medicine and Therapeutics, prior to managing international sales for Quorum Diagnostics, a manufacturer of diagnostic test kits. Immediately prior to starting at BC Biotech, he worked as a sector advisor for biotechnology and medical devices for BC’s Ministry of Employment and Investment.

At the 4 th Annual BioPartnering North America conference held in Vancouver from 5 to 7 February 2006, CAPRA represented a Chinese pharmaceutical company visiting Canada for the first time. CAPRA helped the company to secure a number of meetings with BC-based biotech companies involved in research in fields similar to their own. Following the conference, CAPRA also secured tours of two biotech companies, along with UBC’s University Industry Liaison Office, and introduced them to an experienced Chinese entrepreneur based in Vancouver.

Back Home